Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: An experimental study

Annals of Nuclear Medicine

Volumn 10, Issue 4, 1996, Pages 419-423

  Ercan, Meral T ^a   Gülaldi, Nedim C M ^a   Ünsal, Işil S ^a   Aydin, Mehmet ^a   Peksoy, Irfan ^a   Hasçelik, Zafer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

99mTc(III) DMSA; 99mTc(V) DMSA; 99mTc HIG; arthritis; inflammation

Indexed keywords

OVALBUMIN; SUCCIMER TC 99M; TURPENTINE;

ABSCESS; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; INFLAMMATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCINTIGRAPHY;

EID: 0030466429     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03164803     Document Type: Article

References (19)

1. 99mTc-dimercaptosuccinate complex as a tumor imaging agent. Int J Nucl Med Biol 12: 273-279, 1985.
2. 99mTc(V)-DMSA for tumour and metastasis scintigraphy. Nucl Med Biol 19: 825-830, 1992.
3. Watkinson JC, Allen SJ, Laws DE, et al. The pharmacokinetics and biodistribution of technetium-99m(V) dimercaptosuccinic acid in an animal model. J Nucl Med 32: 1235-1238, 1991.
4. Ohta H, Endo K, FujitaT, et al. Imaging of soft tissue tumors with Tc(V)-99m dimercaptosuccinic acid. A new tumorseeking agent. Clin Nucl Med 9: 568-573, 1984.
5. Watkinson JC, Larazus CR, Mistry R, et al. Technetium99m(V) dimercaptosuccinic acid uptake in patients with squamous carcinoma of the head and neck - Experience in imaging. J Nucl Med 30: 174-180, 1989.
6. Kashyap R, Babber A, Sahai I, et al. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Clin Nucl Med 17: 119-122, 1992.
7. Kobayashi H, Sakahara H, Hosono M, et al. Soft tissue tumors: Diagnosis with Tc-99m(V) dimercaptosuccinic acid scintigraphy. Radiology 190: 277-280, 1994.
8. Blower PJ, Sing J, Clarkc SEM. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 32: 845-849, 1991.
9. Ohta H, Ishii M, Yoshizumi M, et al. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans. Clin Nucl Med 10: 167-170, 1985.
10. 99mTc in experimental abscesses. Nucl Med Biol 21: 143-149, 1994.
11. Gülaldi NCM, Bayhan H, Ercan MT, et al. The visualization of pulmonary tuberculosis with Tc-99m(V) DMS A and Tc99m citrate in comparison to Ga-67 citrate. Clin Nucl Med 20: 1012-1014, 1995.
12. Sampson C. Preparation of Tc-99m(V) DMSA. Nucl Med Commun 8: 184-185, 1987.
13. 99mTc-labelled pentavalent DMSA and its evaluation as a tumor imaging agent. J Nucl Biol Med 35: 100-104, 1991.
14. Consden R, Doble A, Glynn LE, et al. Production of a chronic arthritis with ovalbumin. Its retention in the rabbit knee joint. Ann Rheum Dis 30: 307-315, 1971.
15. 67Ga-citrate for the scintigraphic visualization of inflammatory lesions. Nucl Med Biol 20: 881-887, 1993.
16. m-glutathione for imaging inflammatory lesions. Nucl Med Commun 15: 533-539, 1994.
17. Tzen KY, Oster ZH, Wagner FIN, et al. Role of iron-binding proteins and enhanced vascular permeability in the accumulation of gallium-67. J Nucl Med 21: 31-35, 1980.
18. Hosain F, Haddon MJ, Hosain H, et al. Radiopharmaceuticals for diagnosis and treatment of arthritis. Nucl Med Biol 17: 151-155, 1990.
19. Roizenblatt J, Buchpiguel CA, Menguetti JC, et al. Quantification of ocular inflammation with technetium-99m glucoheptonate. Eur J Nucl Med 18: 955-958, 1991.